Painkiller celecoxib as safe as other prescribed NSAIDS, study finds

A large-scale international study of thousands of arthritis patients has found the risks arising from prescribed use of some of the most common painkillers are relatively low, offering reassurance to doctors and patients.

The SCOT study (Standard Care versus Celecoxib Outcome Trial), published recently in the European Heart Journal and involved academics from The University of Nottingham’s School of Medicine.

It set out to examine the comparative safety of treating arthritis either with commonly used non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, diclofenac and naproxen, or a newer class of more targeted drugs called COX2 inhibitors, which include celecoxib.

Click here to read more.